Lin Xie

Statistics

Publications

Citations

231

H-Index

Active since

2006

Affiliations

Huazhong University of Science and Technology(Current)

Tongji Hospital

Ministry of Education of the People's Republic of China

Taian City Central Hospital

Wuhan University

Lin Xie is an author at Huazhong University of Science and Technology specializing in life sciences, immunology, and myeloid differentiation primary response 88 signaling.

ORCID

Publications per year

2006–2024

Publications

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer

Lin Xie, Fengchao Jiang, Limin Zhang et al. · JNCI Journal of the National Cancer Institute · 2015 · 95 citations · Full text

Medicine, Immunology, Pharmacology +17

Cotransplantation With Xenogenetic Neonatal Porcine Sertoli Cells Significantly Prolongs Islet Allograft Survival in Nonimmunosuppressive Rats

Zhuzeng Yin, Dong Chen, Feng Hu et al. · Transplantation · 2009 · 27 citations

Life Sciences, Endocrinology, Immunology +16

Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection

Lin Xie, M.A. Hassan Talukder, Jian Sun et al. · Journal of Molecular and Cellular Cardiology · 2015 · 25 citations · Full text

Life Sciences, Cardiology, Pharmacology +8

Evaluation of peripheral blood inflammation indexes as prognostic markers for colorectal cancer metastasis

Xin Shen, Mengying Xiang, Jiadai Tang et al. · Scientific Reports · 2024 · 23 citations · Full text

Medicine, Oncology, Pathology +17

Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells

Lu Wang, Dan Hu, Bin Xie et al. · Investigational New Drugs · 2022 · 20 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 8